Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-004230

CVP,Strategy/Corp Development sold 9,500 shares at $69.81 ($663,196)

  • CVP,Strategy/Corp Development acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BOBO DONALD E JR · CVP,Strategy/Corp Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-14 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $45.28 $430,129 56,706.37 D
2025-04-14 Sale : show line 2 in the form 10b5-1 −9,500 $69.81 $663,196 47,206.37 D
Open-market sales · 9,500 sh · avg $69.81 · $663,196

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-14 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −9,500 0 D
Loading xslF345X05/doc4.xml…